| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/27/2011 | CN101067124B Novel peptide synthase gene |
| 07/27/2011 | CN101062952B Fusion protein comprised of human serum and interferon and its coding gene and application |
| 07/27/2011 | CN101062949B Recombinant anti human IgE monoclonal antibody and preparation method and usage thereof |
| 07/27/2011 | CN101041829B Gene encoding glycogen branching enzyme and use thereof |
| 07/27/2011 | CN101035896B Probe of human papillomavirus and DNA chip comprising the same |
| 07/27/2011 | CN101016554B Transgene rape Rf3 event exogenesis insertion carrier side sequence and application thereof |
| 07/27/2011 | CN101010427B Anti-A33 antibody |
| 07/26/2011 | US7987056 Mixed-library parallel gene mapping quantitative micro-array technique for genome-wide identification of trait conferring genes |
| 07/26/2011 | US7985903 Maize variety hybrid X7P212 |
| 07/26/2011 | US7985901 Inbred corn line BD9122BM |
| 07/26/2011 | US7985900 Soybean variety XB12V09 |
| 07/26/2011 | US7985899 Soybean variety XB31AH09 |
| 07/26/2011 | US7985898 Soybean variety D5423851 |
| 07/26/2011 | US7985897 Soybean variety D5235648 |
| 07/26/2011 | US7985896 Soybean cultivar 21151712 |
| 07/26/2011 | US7985894 Soybean variety RJS23001 |
| 07/26/2011 | US7985892 Truncated Cry35 proteins |
| 07/26/2011 | US7985891 Immunization of fish with plant-expressed recombinant proteins |
| 07/26/2011 | US7985890 Transgenic sweet sorghum with altered lignin composition and process of preparation thereof |
| 07/26/2011 | US7985889 AtMIN7 mediated disease resistance to Pseudomonas syringae in Arabidopsis |
| 07/26/2011 | US7985888 Method for increasing seed size by increasing gibberellin content in the seeds |
| 07/26/2011 | US7985887 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2011 | US7985854 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1) |
| 07/26/2011 | US7985852 hTERT gene expression regulatory gene |
| 07/26/2011 | US7985850 Plant genes encoding Dr1 and DRAP1, a global repressor complex of transcription |
| 07/26/2011 | US7985849 B12 dependent dehydratases with improved reaction kinetics |
| 07/26/2011 | US7985842 Anti-IGF-I receptor antibody |
| 07/26/2011 | US7985841 Heterodimeric receptor libraries using phagemids |
| 07/26/2011 | US7985840 Polypeptide fusion comprising complementary determining regions for use as tool in immunotherapeutic and/or diagnostics; bioassay |
| 07/26/2011 | US7985835 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
| 07/26/2011 | US7985833 Collectin |
| 07/26/2011 | US7985739 Generating transgenic cells via insertional event generated by modified transposase; mobile genetic element for use as tool in heterologous gene transfer |
| 07/26/2011 | US7985582 Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof |
| 07/26/2011 | US7985581 Multiple RNA polymerase III promoter expression constructs |
| 07/26/2011 | US7985572 Modified nitrilases and their use in methods for the production of carboxylic acids |
| 07/26/2011 | US7985571 Isolated genomic polynucleotide fragments from chromosome 17 that encode human carboxypeptidase D |
| 07/26/2011 | US7985565 Method of nucleic acid amplification |
| 07/26/2011 | US7985564 Expression systems with sec-system secretion |
| 07/26/2011 | US7985563 HIFαprolyl hydroxylation assay |
| 07/26/2011 | US7985562 Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-lle347 polymorphism |
| 07/26/2011 | US7985553 Using tagged ribosomes as diagnostic tool in detection and isolation of preferential translated messenger RNA species; tissue targeted therapy |
| 07/26/2011 | US7985550 Methods of isolating methylated CpG islands |
| 07/26/2011 | US7985549 Method for predicting responsiveness to TNFα blocking agents |
| 07/26/2011 | US7985548 Materials and methods directed to asparagine synthetase and asparaginase therapies |
| 07/26/2011 | US7985540 Using alternating electric fields to isolate preferential biopolymers from fluids |
| 07/26/2011 | US7985539 Comprises oligonucleotide sequences conjugated to raman labels for highly sensitive and highly selective detection of target sequences in solution; genomics and proteomics |
| 07/26/2011 | US7985411 Activatable recombinant neurotoxins |
| 07/26/2011 | US7985407 Method of treating solid tumor |
| 07/26/2011 | CA2630341C Process for producing isoprenoid compounds by microorganisms |
| 07/26/2011 | CA2569767C Plastid transit peptides |
| 07/26/2011 | CA2551266C Embryonic stem cell line and method for preparing the same |
| 07/26/2011 | CA2487976C Calcitonin gene related peptide receptor antagonists |
| 07/26/2011 | CA2461571C Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 07/26/2011 | CA2453528C Novel fusion proteins and assays for molecular binding |
| 07/26/2011 | CA2448975C Sequences for detection and identification of methicillin-resistant staphyloccocus aureus |
| 07/26/2011 | CA2441225C A novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes |
| 07/26/2011 | CA2438851C Interleukin-18 mutants, their production and use |
| 07/26/2011 | CA2432995C Immunogenic hla-a2 supermotif-restricted peptides |
| 07/26/2011 | CA2431170C Method of analyzing expression of gene |
| 07/26/2011 | CA2411249C Gasc1 gene |
| 07/26/2011 | CA2376346C Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 07/26/2011 | CA2352467C Apoptosis-inducing factor |
| 07/26/2011 | CA2332510C In situ hybridization method for detecting target nucleic acid |
| 07/26/2011 | CA2308113C Multiply-substituted protease variants with altered net charge for use in detergents |
| 07/26/2011 | CA2299677C Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 07/26/2011 | CA2295859C Cytokinin oxidase |
| 07/26/2011 | CA2289912C Human receptor proteins; related reagents and methods |
| 07/26/2011 | CA2221409C Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 07/26/2011 | CA2215350C Transforming growth factor alpha hii |
| 07/26/2011 | CA2213340C Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
| 07/21/2011 | WO2011088435A1 Methods for reducing protein levels in a cell |
| 07/21/2011 | WO2011088309A1 Microrna compositions and methods |
| 07/21/2011 | WO2011088299A1 Plant regulatory elements and uses thereof |
| 07/21/2011 | WO2011088206A1 Production of hydrocarbons in microorganisms |
| 07/21/2011 | WO2011088180A1 Compositions and methods for minimizing nornicotine synthesis in tobacco |
| 07/21/2011 | WO2011088148A1 Modulation of transforming growth factor-beta 1 expression |
| 07/21/2011 | WO2011088081A1 Restrictive inverted terminal repeats for viral vectors |
| 07/21/2011 | WO2011088076A2 Structured rna motifs and compounds and methods for their use |
| 07/21/2011 | WO2011088065A1 Transgenic plants with enhanced agronomic traits |
| 07/21/2011 | WO2011088059A1 Yeast cells expressing amyloid beta and uses therefor |
| 07/21/2011 | WO2011087839A1 Vaccine to influenza a virus |
| 07/21/2011 | WO2011087804A2 Peptide-polynucleotide compositions, and methods for transfecting a cell with dna and treatment of neurodegenerative disease |
| 07/21/2011 | WO2011087787A1 Branched-chain fatty acids and biological production thereof |
| 07/21/2011 | WO2011087178A1 Screening method for the in-vivo active indicator of human mesenchymal stem cells |
| 07/21/2011 | WO2011087092A1 Anti-influenza antibody and influenza detection device |
| 07/21/2011 | WO2011087091A1 Anti-asct2 (system asc amino acid transporter type 2) antibody |
| 07/21/2011 | WO2011087009A1 Regulatory gene controlling saccharometabolism, lipid metabolism, obesity and life, protein, and screening method |
| 07/21/2011 | WO2011086973A1 Antibody specific to activated egfr |
| 07/21/2011 | WO2011086840A1 Photo-sensitive gene expression regulation system |
| 07/21/2011 | WO2011086834A1 Process for production of n-acetyl-d-neuraminic acid |
| 07/21/2011 | WO2011086509A1 Methods of producing adenovirus vectors and viral preparations generated thereby |
| 07/21/2011 | WO2011086447A2 Fermentation process for the preparation of recombinant heterologous proteins |
| 07/21/2011 | WO2011086322A1 Proteins interacting with gcp3 and uses thereof |
| 07/21/2011 | WO2011086195A1 Method for isolating small rna |
| 07/21/2011 | WO2011086189A2 Constructs, vectors and cyanobacteria for the synthesis of fatty alcohols, and methods for producing fatty alcohols in cyanobacteria |
| 07/21/2011 | WO2011086172A1 Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (ibd) and irritable bowel syndrome (ibs) |
| 07/21/2011 | WO2011086143A2 Liver targeting molecules |
| 07/21/2011 | WO2011086141A1 Bacterial host strain expressing recombinant dsbc |
| 07/21/2011 | WO2011086139A1 Bacterial host strain expressing recombinant dsbc and having reduced tsp activity |
| 07/21/2011 | WO2011086138A1 Bacterial host strain comprising a mutant spr gene and a wild-type tsp gene |